Innate Pharma SA Bank Borrowings Undiscounted Cash Flows
Innate Pharma SA (IPHYF) had Bank Borrowings Undiscounted Cash Flows of EUR 23.26 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:BankBorrowingsUndiscountedCashFlows · last filed 2026-04-01
- 2025-12-31: Bank Borrowings Undiscounted Cash Flows 23.26M EUR.
- 2025-06-30: Bank Borrowings Undiscounted Cash Flows 27.03M EUR.
- 2024-12-31: Bank Borrowings Undiscounted Cash Flows 32.10M EUR.
- 2024-06-30: Bank Borrowings Undiscounted Cash Flows 36.87M EUR.
| Period end | Bank Borrowings Undiscounted Cash Flows |
|---|---|
| 2025-12-31 | 23.26M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 27.03M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 32.10M EUR 20-F · filed 2025-04-30 |
| 2024-06-30 | 36.87M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 41.56M EUR 20-F · filed 2024-04-04 |
| 2023-06-30 | 42.65M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 44.53M EUR 20-F · filed 2023-04-06 |
| 2022-06-30 | 43.37M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 45.67M EUR 20-F · filed 2022-04-04 |
| 2021-06-30 | 17.92M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 20.67M EUR 20-F · filed 2021-04-27 |
| 2019-12-31 | 20.59M EUR 20-F · filed 2020-04-24 |